Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Shares Outstanding (2016 - 2021)

Historic Shares Outstanding for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $94.8 million.

  • Neurocrine Biosciences' Shares Outstanding rose 149.89% to $94.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $94.8 million, marking a year-over-year increase of 149.89%. This contributed to the annual value of $93.5 million for FY2020, which is 130.01% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Shares Outstanding of $94.8 million as of Q3 2021, which was up 149.89% from $94.6 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Shares Outstanding high stood at $94.8 million for Q3 2021, and its period low was $88.8 million during Q4 2017.
  • Its 5-year average for Shares Outstanding is $92.2 million, with a median of $92.2 million in 2019.
  • As far as peak fluctuations go, Neurocrine Biosciences' Shares Outstanding surged by 225.23% in 2018, and later skyrocketed by 121.35% in 2019.
  • Neurocrine Biosciences' Shares Outstanding (Quarter) stood at $88.8 million in 2017, then grew by 2.25% to $90.8 million in 2018, then grew by 1.65% to $92.3 million in 2019, then rose by 1.3% to $93.5 million in 2020, then grew by 1.39% to $94.8 million in 2021.
  • Its last three reported values are $94.8 million in Q3 2021, $94.6 million for Q2 2021, and $94.5 million during Q1 2021.